Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sentinel Lymph Node Biopsy in Breast Cancer
NCT00005821Phase 2Unknown
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Dec 1998
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Patent blue V and technetium tc 99m human serum albumin colloid in breast cancer (2 arms), sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: Accuracy of Sentinel Lymph Node Biopsy vs Axillary Dissection. Status: unknown.
02
Drugs
Patent blue Vtechnetium tc 99m human serum albumin colloid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00005821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005821.